2.7299
price down icon0.73%   -0.0201
after-market Dopo l'orario di chiusura: 2.75 0.0201 +0.74%
loading
Precedente Chiudi:
$2.75
Aprire:
$2.77
Volume 24 ore:
17,615
Relative Volume:
0.10
Capitalizzazione di mercato:
$102.67M
Reddito:
-
Utile/perdita netta:
$-13.27M
Rapporto P/E:
-16.65
EPS:
-0.164
Flusso di cassa netto:
$-7.70M
1 W Prestazione:
-3.20%
1M Prestazione:
+11.42%
6M Prestazione:
+163.50%
1 anno Prestazione:
+100.58%
Intervallo 1D:
Value
$2.65
$2.77
Intervallo di 1 settimana:
Value
$2.65
$2.8482
Portata 52W:
Value
$0.8075
$3.11

Okyo Pharma Limited Stock (OKYO) Company Profile

Name
Nome
Okyo Pharma Limited
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
4
Name
Cinguettio
Name
Prossima data di guadagno
2024-09-30
Name
Ultimi documenti SEC
Name
OKYO's Discussions on Twitter

Confronta OKYO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
OKYO
Okyo Pharma Limited
2.7299 103.43M 0 -13.27M -7.70M -0.164
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Okyo Pharma Limited Borsa (OKYO) Ultime notizie

pulisher
Jul 28, 2025

Should I hold or sell OKYO Pharma Limited stock in 2025Capitalize on market shifts before others do - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does OKYO Pharma Limited compare to its industry peersMaximize your returns with expert insights - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Analyzing OKYO Pharma Limited with risk reward ratio chartsFree Growth Based Stock Signal Screener - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What is OKYO Pharma Limited company’s growth strategyAchieve consistent double-digit returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are the latest earnings results for OKYO Pharma LimitedTransform your portfolio with high-yield stocks - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is it the right time to buy OKYO Pharma Limited stockSky-high profits - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What markets is OKYO Pharma Limited expanding into Is BAYA stock a good long term investment option - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are OKYO Pharma Limited company’s key revenue driversMaximize gains with proven stock analysis - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What catalysts could drive OKYO Pharma Limited stock higher in 2025Free Stock Selection - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is the risk reward ratio of investing in OKYO Pharma Limited stockInvest smarter with real-time trading alerts - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 19:17:36 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How Resilient Is OKYO Pharma Limited Stock During Economic DownturnsFast Moving Stock Alerts - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Why OKYO Pharma Limited stock attracts strong analyst attentionMarket Beating Strategy - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

How OKYO Pharma Limited stock performs during market volatilityControlled Risk High Reward Plan - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

OKYO Pharma Limited Stock Analysis and ForecastMarket-beating returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about OKYO Pharma Limited stockMassive stock growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What institutions are buying OKYO Pharma Limited stock nowFree Market Dynamics Reports - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Will OKYO Pharma Limited stock benefit from AI tech trendsExplosive market performance - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

OKYO Pharma reports promising phase 2 results for urcosimod in neuropathic corneal pain - Pharmafile

Jul 24, 2025
pulisher
Jul 23, 2025

What drives OKYO Pharma Limited stock priceAccelerated wealth expansion - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is OKYO Pharma Limited a good long term investmentPhenomenal trading returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 21, 2025

OKYO Pharma Secures $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain - VisionMonday.com

Jul 21, 2025

Okyo Pharma Limited Azioni (OKYO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Capitalizzazione:     |  Volume (24 ore):